New hope for Tough-to-Treat breast cancer
NCT ID NCT04489173
Summary
This study is testing if the drug trifluridine/tipiracil can help control advanced breast cancer that has grown after standard chemotherapy. It is for women with a specific type of breast cancer (ER-positive, HER2-negative) that has spread. The main goal is to see if the treatment can stop the cancer from getting worse for at least 8 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Amphia Ziekenhuis
Breda, Netherlands
-
Catharina Ziekenhuis
Eindhoven, Netherlands
-
Deventer ziekenhuis
Deventer, Netherlands
-
Erasmus MC
Rotterdam, Netherlands
-
MC Leeuwarden
Leeuwarden, Netherlands
-
MUMC
Maastricht, Netherlands
-
Reinier de Graaf Groep
Delft, Netherlands
-
Rijnstate
Arnhem, Netherlands
-
UMC Utrecht
Utrecht, Netherlands
-
Wilhelmina ziekenhuis
Assen, Netherlands
Conditions
Explore the condition pages connected to this study.